Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

被引：7
|
作者：
Dias, Amanda de Fraga [1 ]
Dallemole, Danieli Rosane [2 ]
Bruinsmann, Franciele Aline [2 ]
Lopes Silva, Luiz Fernando [1 ]
Cruz-Lopez, Olga [3 ,4 ]
Conejo-Garcia, Ana [3 ,4 ]
Oliveira Battastini, Ana Maria [1 ]
Maria Campos, Joaquin [3 ,4 ]
Guterres, Silvia Staniscuaski [2 ]
Pohlmann, Adriana Raffin [2 ]
Figueiro, Fabricio [1 ,5 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
[3] Fac Farm, Dept Quim Farmaceut & Organ, C Campus Cartuja S-N, Granada, Spain
[4] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain
[5] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil
来源：
NANOMEDICINE | 2021年 / 16卷 / 23期
关键词：
bozepinib; drug delivery; glioblastoma; intranasal; lipid-core nanocapsules; temozolomide; LIPID-CORE NANOCAPSULES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; INTRANASAL DELIVERY; EXPERIMENTAL-DESIGN; GROWTH-INHIBITION; IN-VITRO; CHITOSAN; COMBINATION; GLIOMA;
D O I：
10.2217/nnm-2021-0164
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To develop and characterize bozepinib-loaded lipid-core nanocapsules (BZP-LNC+) as a potential treatment for glioblastoma (GBM). Methods: Characterization of nanocapsules was performed by diameter, polydispersity index, zeta potential, pH and encapsulation efficiency. GBM cell viability, cell cycle and Annexin/PI were evaluated after BZP-LNC+ treatment. Synergism between BZP-LNC+ and temozolomide (TMZ) was performed by CompuSyn software and confirmed in vitro and in vivo. Results: BZP-LNC+ showed adequate particle sizes, positive zeta potential, narrow size distribution and high encapsulation efficiency. BZP-LNC+ reduces GBM growth by inducing apoptosis. BZP-LNC+ and TMZ showed synergistic effect in vitro and reduced the in vivo glioma growth by approximately 81%. Conclusion: The present study provides proof-of-principle insights for the combination of these drugs for GBM treatment.
引用
收藏
页码：2095 / 2115
页数：21
相关论文
共 50 条
  • [31] Methotrexate-loaded microspheres for nose to brain delivery: in vitro/in vivo evaluation
    Sun, Yu
    Shi, Kai
    Wan, Feng
    Cui, Fu-de
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2012, 22 (02) : 167 - 174
  • [32] Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system
    Ferreira, Natalia N.
    de Oliveira Junior, Edilson
    Granja, Sara
    Boni, Fernanda, I
    Ferreira, Leonardo M. B.
    Cury, Beatriz S. F.
    Santos, Lilian C. R.
    Reis, Rui M.
    Lima, Eliana M.
    Baltazar, Fatima
    Gremiao, Maria Palmira D.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 603
  • [33] Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation
    Masjedi, Moein
    Azadi, Amir
    Heidari, Reza
    Mohammadi-Samani, Soliman
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (10) : 1341 - 1351
  • [34] Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery
    Salade, Laurent
    Wauthoz, Nathalie
    Vermeersch, Marjorie
    Amighi, Karim
    Goole, Jonathan
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 129 : 257 - 266
  • [35] Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
    Bicker, Joana
    Fortuna, Ana
    Alves, Gilberto
    Falcao, Amilcar
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (05) : 594 - 619
  • [36] Mucoadhesive Amphiphilic Methacrylic Copolymer-Functionalized Poly(ε-caprolactone) Nanocapsules for Nose-to-Brain Delivery of Olanzapine
    Fonseca, Francisco N.
    Betti, Andresa H.
    Carvalho, Flavia C.
    Gremiao, Maria P. D.
    Dimer, Frantiescoli A.
    Guterres, Silvia S.
    Tebaldi, Marli L.
    Rates, Stela M. K.
    Pohlmann, Adriana R.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2015, 11 (08) : 1472 - 1481
  • [37] Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
    Battaglia, Luigi
    Panciani, Pier Paolo
    Muntoni, Elisabetta
    Capucchio, Maria Teresa
    Biasibetti, Elena
    De Bonis, Pasquale
    Mioletti, Silvia
    Fontanella, Marco
    Swaminathan, Shankar
    EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (04) : 369 - 378
  • [38] Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview
    Musumeci, Teresa
    Bonaccorso, Angela
    Puglisi, Giovanni
    PHARMACEUTICS, 2019, 11 (03)
  • [39] Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders
    Agnihotri, Tejas Girish
    Jadhav, Govinda Shivaji
    Sahu, Bichismita
    Jain, Aakanchha
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (12) : 3104 - 3120
  • [40] A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles
    Sekerdag, Emine
    Lule, Sevda
    Pehlivan, Sibel Bozdag
    Ozturk, Naile
    Kara, Asli
    Kaffashi, Abbas
    Vural, Imran
    Isikay, Ilkay
    Yavuz, Burcin
    Oguzh, Kader Karli
    Soylemezoglu, Figen
    Gursoy-Ozdemir, Yasemin
    Mut, Melike
    JOURNAL OF CONTROLLED RELEASE, 2017, 261 : 187 - 198
12345